Literature DB >> 8898825

PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats.

H Takahashi1, J R Kirsch, K Hashimoto, E D London, R C Koehler, R J Traystman.   

Abstract

BACKGROUND AND
PURPOSE: We tested the hypothesis that intravenous administration of the potent sigma-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) during transient focal ischemia would decrease postischemic brain infarction volume in rats.
METHODS: Rats underwent intravascular focal ischemia for 2 hours followed by 22 hours of reperfusion. Halothane anesthesia was used only during initiation and cessation of ischemia. Rats received saline (n = 10) or 1 mumol/kg per hour PPBP (n = 10) by continuous intravenous infusion starting 1 hour after the initiation of ischemia and continuing through 22 hours of reperfusion.
RESULTS: There was no difference between groups in blood pressure, arterial blood gas values, and body temperature. Triphenyltetrazolium-determined infarction volume of ipsilateral cerebral cortex (saline, 39 +/- 6%; PPBP, 21 +/- 7% of ipsilateral hemisphere; mean +/- SEM) and striatum (saline, 68 +/- 6%; PPBP, 33 +/- 8% of ipsilateral striatum) was smaller in rats treated with PPBP than in rats treated with saline.
CONCLUSIONS: These data indicate that sigma-receptors may play an important role in the mechanism of injury both in cortex and striatum after 2 hours of transient focal ischemia in rats. Because PPBP afforded protection when administered at the end of ischemia and during reperfusion, sigma-receptors may influence the progression of injury in ischemic border regions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898825     DOI: 10.1161/01.str.27.11.2120

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

Review 1.  Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

Authors:  Linda Nguyen; Brandon P Lucke-Wold; Shona Mookerjee; Nidhi Kaushal; Rae R Matsumoto
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

2.  Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons.

Authors:  Zeng-Jin Yang; Erin L Carter; Michel T Torbey; Lee J Martin; Raymond C Koehler
Journal:  Exp Neurol       Date:  2009-10-31       Impact factor: 5.330

3.  A novel atherothrombotic model of ischemic stroke induced by injection of collagen into the cerebral vasculature.

Authors:  Kathryn J Schunke; Thomas K Toung; Jian Zhang; Arvind P Pathak; Jiadi Xu; Jiangyang Zhang; Raymond C Koehler; Nauder Faraday
Journal:  J Neurosci Methods       Date:  2014-10-12       Impact factor: 2.390

4.  (-)1-(Benzofuran-2-yl)-2-propylaminopentane shows survival effect on cortical neurons under serum-free condition through sigma receptors.

Authors:  W Hamabe; R Fujita; T Yasusa; F Yoneda; A Yoshida; H Ueda
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

5.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

Review 6.  Perinatal hypoxic-ischemic brain injury in large animal models: Relevance to human neonatal encephalopathy.

Authors:  Raymond C Koehler; Zeng-Jin Yang; Jennifer K Lee; Lee J Martin
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-28       Impact factor: 6.200

7.  Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke.

Authors:  Alexander Papangelou; Thomas J K Toung; Allan Gottschalk; Marek A Mirski; Raymond C Koehler
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

8.  Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2.

Authors:  Sufang Yang; Anish Bhardwaj; Jian Cheng; Nabil J Alkayed; Patricia D Hurn; Jeffrey R Kirsch
Journal:  Anesth Analg       Date:  2007-05       Impact factor: 5.108

9.  A prototypical Sigma-1 receptor antagonist protects against brain ischemia.

Authors:  John A Schetz; Evelyn Perez; Ran Liu; Shiuhwei Chen; Ivan Lee; James W Simpkins
Journal:  Brain Res       Date:  2007-09-12       Impact factor: 3.252

10.  Cyclic adenosine monophosphate response element-binding protein phosphorylation and neuroprotection by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP).

Authors:  Sufang Yang; Nabil J Alkayed; Patricia D Hurn; Jeffrey R Kirsch
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.